Trials / Unknown
UnknownNCT04385355
Influence of the Design of the Transmucosal Abutment on the Periimplant Bone Level
Influence of the Design of the Transmucosal Abutment on the Marginal Periimplant Bone Loss. Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- University of Santiago de Compostela · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the radiographic changes on the marginal peri-implant bone level on bone level implants with a narrower transmucosal abutment, in comparison to the conventional abutment, both of 3mm height
Detailed description
Patients will receive from one to eight bone-level implants according to their rehabilitation necessity and transmucosal abutments will be connected the day of the surgery. The control group will receive conventional transmucosal abutments while the test group will receive TCP abutments, with a narrower design. Results will be evaluated initially 6 and 12 months after the connection of the definitive prostheses, and finally 3 years later.
Conditions
- Peri-implant Marginal Bone Loss
- Peri-implant Bone Level
- Transmucosal Abutment Design
- Peri-implant Bone Loss
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Conventional transmucosal abutment design | The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one |
| DEVICE | Narrow transmucosal abutment design | The macroscopic design of the intermediate transmucosal abutment will be evaluated on terms of the marginal peri-implant bone levels using two identical devices, if only being the test device narrower than the control one |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2024-10-31
- Completion
- 2024-11-01
- First posted
- 2020-05-12
- Last updated
- 2021-09-29
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04385355. Inclusion in this directory is not an endorsement.